Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Cannabinoids and Pain -

Cannabinoids and Pain

Samer N. Narouze (Herausgeber)

Buch | Softcover
XIX, 339 Seiten
2021 | 1st ed. 2021
Springer International Publishing (Verlag)
978-3-030-69185-1 (ISBN)
CHF 194,70 inkl. MwSt
  • Versand in 15-20 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken

This book presents a well-balanced view of the potential medical use of cannabinoids in pain. It comprehensively covers the current challenges with medical cannabis utilization and provides recommendations for research and future directions.

Organized into nine sections, the book begins with an introduction to medical cannabis, including its history, regulations, and the general attitudes of pain physicians on cannabis. Section two explores the biological effects of marijuana via the endocannabinoid system and its complex structure of receptors and enzymes. Sections three, four, and five then delve further into pharmacology and the mechanisms of action applicable to cannabinoids in managing pain.

Timely and socially conscious, section six examines the benefits of substituting opioids with cannabinoids for preoperative management. Echoing the book's well-rounded content, sections seven and eight consider the challenges with medical cannabis, including safety and quality control, brain development risks, vaping hazards, and withdrawal. The book then closes with a look at the future of cannabis in medical research.

Thoroughly and equitably composed, Cannabinoids and Pain is an invaluable resource for primary care physicians, pain and palliative care physicians, and oncologists.


lt;p>Samer Narouze, MD, PhD

Northeast Ohio Medical University

Center for Pain Medicine

Western Reserve Hospital

Cuyahoga Falls, OH


History of Cannabis.- Cannabis Regulations.- The demand for medical cannabis education.- Pain physicians and cannabis: attitudes and beliefs.- Cannabis Terminology.- THE ENDOCANNABINOID SYSTEM.- The CB1 Receptors.- The CB2 Receptors.- Endocannabinoids: Anandamide and 2-AG.- Phytocannabinoids:Tetrahydrocannabinol (THC) .- Phytocannabinoids:  Cannabidiol (CBD).- Other Phytocannabinoids.- Cannabinoids Drug interaction.- Dronabinol (Marinol).- Nabilone (Cesamet).- Cannabidiol (Epidiolex).- Nabiximols (Sativex).- Medical Cannabis Strains.- The model of a specialized cannabis clinic.- Barriers for the prescription of cannabis-based medicines .- Practical recommendations for the use of medical cannabis.- Medical Cannabis Dosing and Titration.- Patient safety considerations.- Cannabinoids and Pain: Mechanisms of action .- Cannabinoids and Pain: Clinical Evidence.- Cannabinoids and Cancer Pain.- Cannabinoids as a substitute for opioids: Basic science and Clinical evidence.- Cannabiinoids as a substitute for opioids: Suggested algorithm .- Perioperative management of patients on cannabinoids.- The Colorado Experience.- Product Safety and Quality control.- Cannabis and brain development.- Cannabis and mental health risks.- Cannabis and adolescents.- Cannabis and child development during and after pregnancy.- Cannabis impairment and Adverse events.- Vaping hazards.- Cannabis Use Disorder.- Cannabis withdrawal  .- Future research.

Erscheinungsdatum
Zusatzinfo XIX, 339 p. 60 illus., 47 illus. in color.
Verlagsort Cham
Sprache englisch
Maße 178 x 254 mm
Gewicht 834 g
Themenwelt Medizin / Pharmazie Gesundheitswesen
Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Medizin / Pharmazie Medizinische Fachgebiete Schmerztherapie
Schlagworte Cancer • Cannabinoids • Cannabis • Endocannabinoid system • medical marijuana • Pain
ISBN-10 3-030-69185-3 / 3030691853
ISBN-13 978-3-030-69185-1 / 9783030691851
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Wie bewerten Sie den Artikel?
Bitte geben Sie Ihre Bewertung ein:
Bitte geben Sie Daten ein:
Mehr entdecken
aus dem Bereich

von Hannes Leischner

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
CHF 37,80

von Stein Husebø; Gebhard Mathis; Eva Katharina Masel

Buch | Softcover (2023)
Springer (Verlag)
CHF 69,95